![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Chongqing Kangle Pharmaceutical Co., Ltd. Chongqing City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Hydroxychloroquine sulfate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2022-022 - Rev 00
This Chemical Type CEP, issued on June 26, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2849 associated with this CEP further emphasizes